Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors. [electronic resource]
Producer: 20060424Description: 156-62 p. digitalISSN:- 0939-4753
- Cannabinoid Receptor Antagonists
- Cardiovascular Diseases -- etiology
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2 -- complications
- Humans
- Hyperlipidemias -- complications
- Metabolic Syndrome -- complications
- Obesity -- complications
- Piperidines -- pharmacology
- Pyrazoles -- pharmacology
- Rimonabant
- Risk Factors
- Smoking Cessation
- Tobacco Use Disorder -- drug therapy
- Treatment Outcome
- Weight Gain -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.